Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Olema Oncology
665 3rd St., Suite 250
San Francisco, CA 94107
Phone: 415-742-8265
https://www.olemapharma.com/

Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women's cancers. The Company's lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.

Key Contact
Name
Cyrus Harmon
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
07/24/20 $54,000,000 Series B BVF Partners
Cormorant Asset Management
Foresite Capital
Janus Henderson Investors
Logos Capital
RA Capital Management
Surveyor Capital
Venrock Healthcare Partners
Wellington Management Company